Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
life sciences
national blog main
new york blog main
3
×
new york top stories
san francisco blog main
san francisco top stories
biotech ipos
deals
dihydroergotamine
investing
medical device
nirogacestat
satsuma pharmaceuticals
springworks therapeutics
10x genomics
acute migrane
acute myeloid leukemia
alx oncology
autoimmune diseases
bain capital
bausch health
berkeley lights
boston blog main
boston top stories
breast cancer
cancer drugs
cancer immunotherapy
cd47
chronic kidney disease
deerfield healthcare technology acquisitions
deerfield management company
desmoid tumor
desmoid tumors
dihydroergotamine mesylate
europe blog main
europe top stories
fda
generic drug
What
biotech
3
×
companies
3
×
ipo
days
hasn’t
ipos
life
satsuma
science
slowed
springworks
street
wall
week
welcomed
activity
arrival
boost
dog
drug
firm
followed
genomics
haul
industry
leading
led
line
market
markets
migraine
momentum
new
pfizer
place
prep
public
raised
research
securing
Language
unset
Current search:
biotech
×
companies
×
" new york blog main "
×
@xconomy.com
3 years ago
Two Days, Six IPOs, and $1B Raised for Biotech Research & More
@xconomy.com
4 years ago
SpringWorks and Satsuma Boost This Week’s Biotech IPO Haul to $595M
@xconomy.com
4 years ago
Pfizer Spinout SpringWorks, Migraine Drug Firm Satsuma Prep IPOs